22nd Century Group, Inc. (NASDAQ: XXII) Reports Weak Q4 Results While Expanding VLN Distribution22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on reduced-nicotine cigarettes, reported fourth-quarter 2025 results that came in below analyst expectations, while continuing to expand distribution of its VLN® products. VLN cigarettes were authorized by the FDA in 2021 as modified risk tobacco products with certain reduced-exposure claims related to nicotine consumption.On March 26, 20 ...